MBL77 OPTIONS

mutations offered the fact that, as defined down below, CLL therapy relies around the presence or absence of such mutations. The present consensus is usually that, other than clonal mutations, subclonal mutations that has a variant allelic frequency starting from five to ten% (and so down below the threshold of detection by regular molecular method